Einträge von Chinot, Olivier auf dem Publikationsserver

Hertler, Caroline, Felsberg, Jörg, Gramatzki, Dorothee , Le Rhun, Emilie, Clarke, Jennifer , Soffietti, Riccardo, Wick, Wolfgang , Chinot, Olivier, Ducray, François, Roth, Patrick, McDonald, Kerrie, Hau, Peter, Hottinger, Andreas F., Reijneveld, Jaap, Schnell, Oliver, Marosi, Christine, Glantz, Michael, Darlix, Amélie, Lombardi, Giuseppe, Krex, Dietmar, Glas, Martin, Reardon, David A., van den Bent, Martin , Lefranc, Florence, Herrlinger, Ulrich, Razis, Evangelia, Carpentier, Antoine F., Phillips, Samuel, Rudà, Roberta, Wick, Antje , Tabouret, Emeline, Meyronet, David, Maurage, Claude-Alain, Rushing, Elisabeth, Rapkins, Robert, Bumes, Elisabeth, Hegi, Monika, Weyerbrock, Astrid, Aregawi, Dawit, Gonzalez-Gomez, Christian, Pellerino, Alessia , Klein, Martin, Preusser, Matthias , Bendszus, Martin, Golfinopoulos, Vassilis, von Deimling, Andreas, Gorlia, Thierry, Wen, Patrick Y., Reifenberger, Guido und Weller, Michael (2023) Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders’ Collaborative Consortium (EORTC 1419). European Journal of Cancer 189, S. 112913. Volltext nicht vorhanden.

Seliger, Corinna, Genbrugge, Els, Gorlia, Thierry, Chinot, Olivier, Stupp, Roger, Nabors, Burt, Weller, Michael und Hau, Peter (2020) Use of metformin and outcome of patients with newly diagnosed glioblastoma: Pooled analysis. International Journal of Cancer 146 (3), S. 803-809. Volltext nicht vorhanden.

Reijneveld, Jaap C., Taphoorn, Martin J. B., Coens, Corneel, Bromberg, Jacoline E. C., Mason, Warren P., Hoang-Xuan, Khê, Ryan, Gail, Hassel, Mohamed Ben, Enting, Roelien H., Brandes, Alba A., Wick, Antje, Chinot, Olivier, Reni, Michele, Kantor, Guy, Thiessen, Brian, Klein, Martin, Verger, Eugenie, Borchers, Christian, Hau, Peter, Back, Michael, Smits, Anja, Golfinopoulos, Vassilis, Gorlia, Thierry, Bottomley, Andrew, Stupp, Roger und Baumert, Brigitta G. (2016) Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study. The Lancet Oncology 17 (11), S. 1533-1542. Volltext nicht vorhanden.